Name | Type | Posted | Actions |
|---|---|---|---|
SS Notice.pdf | Mar 10, 2026 |
SOURCES SOUGHT IHS NSSC ANNUAL INFLUENZA VACCINES
Contact and place of performance
Carlene Prince
Oklahoma City, OK 73114
USA
FOR INFORMATIONAL PURPOSES ONLY This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Pursuant to 48 CFR Part 326, Subpart 326.603-3 and IHM 5.5-6, Indian Health Service must use the negotiation authority of the Buy Indian Act, 25 U.S.C. 47, to give preference to Indian Economic Enterprises (IEE) whenever the use of that authority is authorized and practicable....
View moreThe NAICS code for this requirement is 325414 - Biological Product (except Diagnostic) Manufacturing.
Indian Small Business Economic Enterprises (ISBEEs) and other small business are highly encouraged to respond to this notice. However, firms should understand that generic capability statements are not sufficient for effective evaluation of their capacity and capability to perform the work required. Responses must directly demonstrate the company’s capability, experience, and ability to provide IHS NSSC Annual Influenza Vaccines.
The Government requests interested parties submit a written response to this notice, which includes:
a. Company Name.
b. Company Socioeconomic Status.
c. Company System for Award Management (SAM) Unique Entity Identifier (UEI) number.
d. Company point of contact, mailing address, and telephone number(s), and website address
e. Name, telephone number, and e-mail address of a company point of contact who has the authority and knowledge to clarify responses with government representatives.
f. DUNS Number:
g. Cage Code:
h. Tax ID
i. Date submitted.
j. Applicable company GSA Schedule number or other available procurement vehicle.
k. Company’s System for Award Management (SAM) registration status. All respondents must register on the SAM located at http://www.sam.gov/.
l. Submit Indian Health Service Buy Indian Act Indian Economic Enterprise Representation Form (attached)
Disclaimer and Important Notes. This notice does not obligate the Government to award contract. Any information provided by industry to the Government as a result of this sources sought synopsis is strictly voluntary. Responses will not be returned. No entitlements to payment of direct or indirect costs or charges to the Government will arise as a result of contractor submission of responses, or the Government's use of such information or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published on a government GPE. However, responses to this notice will not be considered adequate responses to a solicitation.
Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
How to respond: Please include the notice IHS NSSC Annual Influenza Vaccines in the subject line. Responses must be submitted via email to the Contract Specialist, Carlene Prince at [email protected] no later than 4:00 PM CST on March 25, 2026.
Capability statements will not be returned and will not be accepted after the due date. The maximum number of pages for this submission is five (5) pages. Respondent must be a Direct Manufacturer.
The Indian Health Service is conducting market research to identify Indian Small Business Economic Enterprises (ISBEE) capable of serving as direct manufacturers for annual influenza vaccines. This sources sought notice, identified by solicitation number SS-IHS-NSSC-03102026, supports the agency’s requirement for vaccine variations tailored to infants, children, adolescents, adults, and the elderly, as well as egg-free formulations. The procurement is classified under NAICS code 325414 Biological Product (except Diagnostic) Manufacturing and PSC 6505 DRUGS AND BIOLOGICALS.
In accordance with the Buy Indian Act, the government is seeking to determine the feasibility of an ISBEE Indian Small Business Economic Enterprise set-aside for this requirement. The primary place of performance is Oklahoma City, OK. Interested direct manufacturers are requested to provide capability statements that demonstrate their experience and capacity to supply these vaccines to the Indian Health Service National Supply Service Center.
Responses must be submitted to Contract Specialist Carlene Prince via email no later than 4:00 PM CST on March 25, 2026. Submissions are limited to five pages and must include a completed Indian Economic Enterprise Representation Form along with company details such as the Unique Entity Identifier (UEI), CAGE code, and applicable GSA schedule numbers. This notice was published on March 10, 2026, and includes one attachment titled SS Notice.pdf.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.